1. Home
  2. PRVA vs QURE Comparison

PRVA vs QURE Comparison

Compare PRVA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

N/A

Current Price

$20.40

Market Cap

3.0B

Sector

Technology

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$44.66

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRVA
QURE
Founded
2007
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
PRVA
QURE
Price
$20.40
$44.66
Analyst Decision
Buy
Buy
Analyst Count
12
14
Target Price
$31.17
$45.00
AVG Volume (30 Days)
990.2K
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
29.67
EPS
0.09
N/A
Revenue
$2,122,842,000.00
$13,107,000.00
Revenue This Year
$18.19
$126.12
Revenue Next Year
$10.72
$200.43
P/E Ratio
$226.89
N/A
Revenue Growth
22.26
N/A
52 Week Low
$19.53
$8.73
52 Week High
$28.82
$71.50

Technical Indicators

Market Signals
Indicator
PRVA
QURE
Relative Strength Index (RSI) 27.73 46.29
Support Level $19.62 $39.50
Resistance Level $23.99 $51.09
Average True Range (ATR) 0.52 2.04
MACD 0.08 -0.69
Stochastic Oscillator 11.70 23.65

Price Performance

Historical Comparison
PRVA
QURE

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: